Brief: Camurus Gains EMA Orphan Drug Status for Octreotide SC Depot

Camurus AB

20/09/2024 07:10

Sept 20 (Reuters) - Camurus AB  CAMX.ST :
    * EMA POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION TO
CAMURUS'
OCTREOTIDE SC DEPOT FOR THE TREATMENT OF POLYCYSTIC LIVER
DISEASE
    * EUROPEAN COMMISSION IS NOW ASSESSING OPINION AND IS
EXPECTED TO
GRANT DESIGNATION WITHIN 30 DAYS.

Source text for Eikon:  ID:nWkr91qvyh 
Further company coverage:  CAMX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))